CUSIP: 89620X506
Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,510,493
-
Share change
-
+62,241
-
Total reported value
-
$44,252,000
-
Price per share
-
$12.61
-
Number of holders
-
26
-
Value change
-
+$731,076
-
Number of buys
-
10
-
Number of sells
-
12
Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q4 2015
As of 31 Dec 2015,
TRILLIUM THERAPEUTICS INC - COM NEW was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,510,493 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, Private Capital Advisors, Inc., FRANKLIN RESOURCES INC, EverPoint Asset Management, LLC, venBio Select Advisor LLC, MILLENNIUM MANAGEMENT LLC, BAKER BROS. ADVISORS LP, Opaleye Management Inc., Point72 Asset Management, L.P., and DEERFIELD MANAGEMENT CO.
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.